Search
Search Results
##search.searchResults.foundPlural##
-
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1242PDF: 472HTML: 18565Figure 1: 168Figure 2: 149Figure 3: 167Figure 4: 203Figure 5: 175 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1099PDF: 485HTML: 8162 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
721PDF: 833PDF Supp. Files: 76HTML: 186 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4084PDF: 1579HTML: 940 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1163PDF: 601HTML: 6797 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2260PDF: 1815HTML: 141 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3289PDF: 2264HTML: 23320Untitled: 203Untitled: 215Untitled: 229 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3227PDF: 1330HTML: 4129 -
DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA
2896PDF: 1583HTML: 232 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1171PDF: 828HTML: 3358 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1082PDF: 421HTML: 240 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4351PDF: 905HTML: 1323Table1: 179 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
936PDF: 568HTML: 2189Cover Letter: 190 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12333PDF: 1675HTML: 4165Cover letter: 196Figure 1: 202 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
1927PDF: 1159HTML: 265 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3282PDF: 1337HTML: 2625 -
-
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
835PDF: 486HTML: 1302 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1523PDF: 387HTML: 208 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1802PDF: 803HTML: 10231Figures 1,2,3: 172 -
THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies
3047PDF: 1844HTML: 234 -
ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS Anorectal pathologies in leukemias
1173PDF: 721Html: 94 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1753PDF: 1068HTML: 245 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3735PDF: 1560HTML: 8030Randi Fig: 180 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3045PDF: 872HTML: 7162Kost Fig1: 181Kost Fig 2: 177Kost Fig3: 174Kost Fig 4: 188Kost Fig5: 184Kost fig 6: 173 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1450PDF: 1051HTML: 215







